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                                                        ABSTRACT                                                                        
STUDY  ON  SPECTRUM OF RENAL DISEASES IN ELDERLY PATIENTS 
ATTENDING A TERTIARY CARE HOSPITAL 
M.Edwin Fernando ,  M.Veerapandian 
BACKGROUND: 
The aim of the study is to study the  pattern of renal diseases in 
elderly subjects and the etiology  causing them in patients attending 
Stanley medical college, Chennai. 
MATERIALS AND METHODS:  Elderly patients above 65 years (n=75) 
attending nephrology outpatient department from June 2014 to 
September 2014 ,with raised urea, creatinine  values ,abnormal 
urinalysis reports and electrolyte imbalance were analysed. 
RESULTS : The study population included 48 males and 27 female 
patients . CKD was seen in 49.33% patients. AKI reported in 36% 
patients. . Sepsis contributed to  large part of AKI (44.4%). 
dehydration due to  gastroenteritis  contributed to AKI  in 29.62% 
patients. Other causes are BPH in 14.81%   and  Carcinoma  cervix in 
3.7% patients. . Glomerular diseases  were  seen in 6 patients (8%) . 
This includes membranous nephropathy (2 patients),   acute 
glomerulonephritis (2 patients) and myeloma kidney seen in 2 
patients.  Other diseases   seen   in  6.66% of study population. This 
includes polycystic kidney seen in 3 patients, simple cysts in 2 
patients. 
CONCLUSION  :  Good control of diabetes and hypertension in 
younger age  may prevent the occurrence of CKD as they grow older. 
Elderly patients should avoid taking over the counter drugs. 
KEY WORDS  : India ; Elderly patients ; renal diseases; spectrum 
1 
 
INTRODUCTION 
    One of the most striking changes in the demography of the world 
has been the increased proportion of elderly individuals in the 
population, who are considered as the  “Geriatric” individuals of age 65 
years and above. 
The relevance of this to health and social services is that there is 
exponential increase in disability and mental and physical morbidity in 
geriatrics. 
Ageing can be described from a physiologic standpoint ,as a   
progressive constriction of the homeostatic reserve of every organ 
system .This decline referred  to as homeostasis  is  evident  by the third 
decade and is then gradually progressive. 
Alterations in kidney function occur  with advancement of age 
.Increased susceptibility to systemic diseases and exposure to multiple 
drugs  makes the elderly people more likely to kidney diseases. This    
study is about the various pattern of renal diseases among elderly 
patients and various etiological factors causing them. 
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AIM  OF THE STUDY 
The aim and objectives of the study are : 
1. TO STUDY THE PATTERNS OF RENAL DISEASES IN 
ELDERLY PATIENTS 
2.  TO  STUDY THE VARIOUS ETIOLOGIES AFFECTING  
KIDNEY FUNCTION IN ELDERLY  PATIENTS 
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REVIEW OF LITERATURE 
HISTORICAL REVIEW 
Glomerular filtration rate : 
The modern era of kidney function assessment began with the 
measurement  Of urea. Urea was first isolated from human urine by  
Rouelle  in 1773. In the  early 1800s,  Fourcroy coined the term “ urue”, 
carefully choosing a name that  would  avoid confusion with  “urique or 
uric acid”. 
 In 1827, Richard  Bright observed that urea accumulated in the 
blood of patients with dropsy and he  linked this phenomenon to 
decreased urine urea concentration, proteinuria and diseased kidneys. 
One year later, Wohler synthesized urea from ammonium cyanate; in so 
doing he helped discredit the doctrine of vitalism, which was then 
prevalent. 
 In 1842, Dumas and Cahours demonstrated that urea was a 
product of dietary protein catabolism and in 1903,strauss introduced 
blood urea level as a diagnostic test for kidney disease. 
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Homer  Smith  credited  Ambard  and  Weil  with  one  of  the  first  
attempts to measure kidney function “dynamic” test in 1912 .  These 
researchers characterized kidney function (K) as blood urea 
concentration (B) divided by the product of the square root of the urea 
excretion(D) times the square root of urine urea concentration (U), as 
follows: 
K = B(√D ×√ U) 
In 1926,Rehberg used exogenous creatinine to measure renal 
clearance as a measure of glomerular filtration. In 1928, Addis 
described kidney function as a urea excretion ratio, or the quantity of 
urea excreted divided by   the concentration in blood. Around the same 
time, the concept of urea clearance as a measure of kidney function was 
described in detail by Moeller, McIntosh and Vanslyke. 
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Embryology of kidney: 
The embryological development of kidney has three stages: the 
pronephros, mesonephros, and metanephros. The pronephros is the early 
stage and metanephros is most developed. The metanephros develops 
into adult kidney. 
During the 5th week of pregnancy, the mesonephric duct forms  an 
outpouching, known as ureteric bud, near the  attachment to the cloaca. 
This bud, also known as  the metanephrogenic diverticulum, develops  
backwards and towards the head of the embryo.  
The elongated stalk of the ureteric bud, known as metanephric 
duct  which develops into  the ureter.  The cranial end of the bud  
undergoes progressive division to form the collecting duct system of the 
kidney. It also forms the renal pelvis, major and minor calyces. 
The metanephrogenic blastema develops from the intermediate 
mesoderm which is in contact with branching ureteric bud.  The meta 
nephrogenic blastema differentiates into the renal tubules.  
The renal tubules develop and  join with connecting tubules of the 
collecting duct system, forming a continuous tube  for flow of urine 
from the renal tubule to the collecting duct. At the same time, precursors 
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of vascular endothelial cells develop to assume their position at the tips 
of  the  renal  tubules.  These  cells  develop  into  the  cells  of  the  future  
glomerulus. 
In  humans,  all  of  the  divisions  of  the  ureteric  bud  and  the  
nephronic units are formed by 32 - 36 weeks of pregnancy. These 
structures are not yet fully developed and will continue to mature after 
birth. Once matured, each human kidney   will have about  1  million 
nephrons. 
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ANATOMY OF KIDNEYS: 
The  kidneys  are  a  paired  organs  situated  one   on  either  side  of   
inferior vena cava and aorta . They are retroperitoneal organs. They 
extend between 12th thoracic and third lumbar Vertebrae. The right 
kidney is slightly lower than left. They weigh about 150g in males and 
135g in females. They have a length about 10-12 cm, width about  
5-7cm , and  thickness about 2-3 cm 
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RELATIONS: 
Superiorly, suprarenal glands  lie  adjacent to the upper pole of 
each  kidney.  On  the  right  side,  the  second  part  of  the  duodenum  is  
related to the inner aspect of the kidney  
On the left side, the greater curvature of the stomach is related to 
superomedial aspect of the kidney, and the tail of the pancreas may 
extend to overlie the renal hilum 
The spleen is located anterior to the upper pole and is connected 
by the splenorenal ligaments. Posteriorly diaphragm is related to upper 
end of each kidney. The kidney  lies over psoas muscle medially and 
quadratus lumborum laterally. 
BLOOD SUPPLY: 
The kidneys receive 20% of cardiac output. They are supplied by 
paired renal arteries. The renal artery divides into 5 segmental arteries 
which branches into interlobar arteries.  The interlobar arteries gives rise 
to arcuate arteries which inturn leads to interlobular arteries. The 
interlobular arteries become afferent arteriole then peritubular 
capillaries and finally efferent arterioles. 
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Venous drainage is mainly by renal vein which lies anterior to the 
artery at the hilum. The left suprarenal and gonadal vein drains into left 
renal vein while on the right side they drain directly into IVC 
Lymphatic drainage follows the venous drainage. The left kidney 
drains into Lt.lateral aortic lymph nodes while right kidney drains to 
Rt.caval nodes. 
Nerve supply: 
The kidney receives autonomic supply via the parasympathetic 
and sympathetic portions of  nervous system. The preganglionic 
sympathetic nervous innervation to the kidneys arises from the T8-L1 
segments of spinal cord. 
Activation of  sympathetic system causes vasoconstriction of the 
renal vessels. Parasympathetic innervation arises from the vagus nerve, 
and causes vasodilation when stimulated. 
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Microscopic structure:   
Each kidney contains about 1 million nephrons. 
A nephron is mainly made up of glomerulus which drain into 
tubules.  
Both human kidney contain about 1.8 million glomeruli. Each 
glomerulus consists of an afferent arteriole, efferent arteriole and 
Bowman’s  capsule.  
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The afferent arteriole derived from the terminal branches of renal 
artery divides into tuft of capillaries embedded in mesangium and 
reunite to form an efferent arteriole which drains into peritubular 
capillaries. 
  Glomerular capillary wall is made up of, from inside to outside, 
endothelium, basement membrane and visceral epithelium. There are 
two types of epithelial cells, one is visceral epithelium which covers the 
glomerular capillaries and other is the parietal  epithelium that coats the 
Bowmans’s membrane from inside. 
  The visceral epithelium is a specialized cell which has a lot of 
foot process called podocytes which covers the capillaries. The 
mesangium  contains  a  group  of  cells  which  are  similar  to  pericytes  of  
blood vessels and extracellular matrix.  
Mesangium secretes many biologically active substances. The 
endothelium has many fenestrations made by foot processes. The 
distance between two foot process is about 20-30 nm which are called as 
“filtration slits”. It allows substances of size less than 70 kilodaltons 
only and it is impermeable to proteins which are larger material. 
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Glomerular basement membrane: 
    Renal glomerular basement membrane is a unique structure which 
has selective permeability. It has three layers a thick outer electron 
dense layer lamina densa in the middle and electron lucent lamina rara 
interna  inside and lamina rara externa  outside. The GBM is mainly 
made up of collagen type IV and other substances like fibronectin, 
laminin, entactin, proteoglycans  and  glycoproteins.  The foot  
processes  are bridged by nephrin molecule  which get attached to 
Podocinin cell membrane connected to actin filaments inside the cell. 
 
Mutations in these proteins are responsible for many diseases. 
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Functions of Glomerulus: 
The  major  function  of  glomerulus  is   filtration.  The  GBM  is  a  
selectively permeable membrane with charge selectivity and size 
selectivity. The GBM is made up of negatively charged proteoglycans 
which repels the  negative charged albumin like substances. The size 
selectivity is important that electrolytes, water, inulin are freely filtered 
whereas albumin and myoglobin are not filtered. Many of the water 
soluble drugs and normal metabolites of body are filtered only through 
kidneys. 
The mesangium is a specialized connective tissue which 
surrounds glomerular capillaries and fills the spaces between endothelial 
surfaces that are not invested by podocytes Mesangium is made up of 
pericytes, phagocytes, Juxtaglomerular cells and some paracrine cells 
which has number of functions. It secretes  prostaglandins, nitric oxide 
and proinflammatory cytokines. 
The glomerulus is  connected to renal tubule. The renal tubule is 
divided into proximal tubule, ascending and descending loops of henle,  
distal convoluted tubule.  
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The human proximal convoluted tubule is about 15 mm long and 
55 um in diameter. Its wall is made up of a single layer of cells that are 
closely connected  with one another and are united by apical tight 
junctions.  The luminal side of the cells have a  brush border due to the 
presence of microvilli. The  proximal tubule  drains into the straight 
portion (pars recta), which forms   the first part of the Henle’s loop. The 
proximal tubule terminates in the thin segment of the descending limb 
of the loop of Henle.  
The nephrons with glomeruli in the outer portions of the renal 
cortex have short loops of Henle(cortical nephrons), whereas those with 
glomeruli in the juxtamedullary region of the cortex (juxtamedullary 
nephrons) have long loops.  
 
The total length of the thin segment of the loop varies from 2 to 
14 mm. It ends in the thick segment of the ascending limb, which is 
about 12 mm in length. The cells of the thick ascending limb are cuboid.  
 
The thick ascending limb of the loop of Henle passes close to the 
glomerulus of the nephron from which the tubule arose. The lining 
epithelium  of the afferent arterioles contain the juxtaglomerular cells. 
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At this junction,  epithelium of the proximal tubule  is modified  to form 
the macula densa.  
The  maculadensa,   juxtaglomerular cells   and the lacis cells near 
them are known collectively as the juxtaglomerular apparatus. 
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The distal convoluted tubule is about 5 mm long. It has few 
microvilli but no distinct brush border. The distal tubules join to form 
collecting ducts that  measures 20 mm in length and pass through  renal 
cortex and medulla to drain into the pelvis of the kidney at the apexes of 
the  pyramids. 
 The epithelium of the collecting ducts is made up of principal 
cells  (P cells) and intercalated cells (I cells). The P cells,  are relatively 
tall and  have few organelles. They are involved in Na+ reabsorption 
and vasopressin-stimulated water reabsorption.  
The I cells  have more microvilli, cytoplasmic vesicles, and 
mitochondria. They are involved  in acid secretion and bicarbonate  
transport.  
The collecting duct system includes the connecting   tubule and 
collecting duct. The collecting ducts may be subdivided into cortical  
and medullary ducts. The collecting ducts fuse and open finally as 
papillary ducts into the renal pelvis. 
 Cortical nephrons perform most of glomerular filtration  because 
their afferent arterioles are larger than efferent arteriole. The juxta 
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medullary nephrons create a hyperosmolar gradient for concentrating 
urine. 
RENAL BLOOD FLOW: 
Renal blood flow can be measured  can be determined by 
applying the Fick principle  to the kidney—ie, by measuring the amount 
of a given substance  taken up per unit of time and dividing this value 
by the arteriovenous difference for the substance across the kidney. 
Since the kidney filters plasma,  the renal plasma flow equals the 
concentration of a substance excreted per unit of time divided by the 
renal AV difference. 
Any excreted substance can be used if its concentration in arterial 
and renal  venous plasma can be measured and if it is not metabolized, 
stored, or  produced by the kidney and does not itself affect blood flow.  
Renal plasma flow can be measured by infusing  p-aminohippuric 
acid (PAH) and determining its urine and plasma concentrations. PAH 
is filtered by the glomeruli and secreted by the tubular cells, so that  
its extraction ratio (arterial concentration minus renal venous 
concentration divided by arterial concentration) is high. 
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  The value obtained should be called the effective renal  plasma 
flow (ERPF) . In humans, ERPF averages about 625 mL/min 
Glomerular filtration rate: 
Filtration is determined mainly by size of  the molecule and shape 
of the solute and also by its charge. Substances with size  exceeding 4 
nm are not filtered. The negatively charged GBM also restricts the 
filtration of proteins like albumin. 
Autoregulation of GFR is the result of 3 factors : myogenic 
reflex, Tubulo Glomerular feedback and angiotensin II mediated 
vasoconstriction of  efferent arteriole. 
Characteristics of an ideal exogenous or endogenous marker: 
1.safe and convenient 
2.readily diffusible in extracellular spaces.  
3. freely filterable 
4.  No tubular reabsorption 
5.No tubular secretion 
6. No extrarenal elimination or degradation 
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7. No compounds interfere 
8.  inexpensive 
9.No influence on GFR. 
Glomerular  filteration cannot be measured directly. If a 
substance in stable concentration in the plasma is physiologically inert, 
freely filtered at the glomerulus and neither secreted, reabsorbed nor 
metabolized by the kidney ,the amount  of that substance filtered at the 
glomerulus is equal to the amount excreted in the urine.  Inulin has each 
of the above properties and has long been considered an ideal substance  
to estimate GFR.   
The amount of inulin filtered at the glomerulus equals the GFR 
multiplied by the plasma inulin concentration : GFR × Pᵢn.  The amount 
of excreted inulin equals the urine inulin concentration (Uᵢn) multiplied 
by the urine flow rate (V). 
Since filtered inulin= excreted inulin: 
       GFR × Pᵢn =   Uᵢn  × V 
 GFR     =( Uᵢn  ×V)/ Pᵢn 
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The factors regulating filtration across the glomerular capillaries 
are the same  as those governing filtration across all other capillaries,ie, 
the  size of the capillary bed, the permeability of the capillaries, and the  
hydrostatic and osmotic pressure gradients across the capillary wall. For 
each nephron:  
GFR=Kf[ ( PGc –Pt)- (ߨGc- ߨt)] 
Kf, the glomerular ultrafiltration coefficient, the product of  its 
permeability and the effective filtration surface area. PGC is the mean 
hydrostatic pressure in the glomerular  capillaries, Pt the mean 
hydrostatic pressure in the tubule, πGC the osmotic pressure of the 
plasma in the glomerular capillaries, and πt  the osmotic pressure of the 
filtrate in the tubule. 
The amount of protein in the urine is normally less than 100 
mg/d, and most  of this is not filtered but comes from shed tubular cells. 
The presence of  significant amounts of albumin in the urine is called 
albuminuria. In nephritis,  the negative charges in the glomerular wall 
are dissipated, and albuminuria  can occur for this reason without an 
increase in the size of the "pores" in the  membrane.  
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Na+ Reabsorption  
The reabsorption of sodium and Chloride  has a important role in  
electrolyte and water metabolism. In addition, Na+ transport is coupled 
to the transport  of H+, other electrolytes, glucose, amino acids, organic 
acids, phosphate, and other substances across the tubule walls. 
 
Sodium   is   transported  by  means  of  active  transport  out  of  all  
parts  of   renal  tubule except  thin portions of  the loop of Henle.  Na+ is  
pumped into the interstitium by Na+-K+ ATPase. It extrudes three  
Na+ in exchange for two K+ that are pumped into the cell.  Much of the 
Na+ is actively transported into the lateral intercellular spaces . 
 
Glucose, amino acids, and bicarbonate are reabsorbed along with 
sodium in  the early part of the proximal tubule .  Glucose is removed by  
means of secondary active transport. It is filtered at a rate of 
approximately 100mg/min . Most of the glucose is reabsorbed. Only  a 
few milligrams appear in the urine per 24 hours.  
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The amount reabsorbed is proportionate to the amount filtered 
and hence to  the plasma glucose level (PG) multiplied by the GFR up to 
the transport  maximum (TmG); but when the TmG is exceeded, the 
amount of glucose in  the urine rises . The TmG is about 375 mg/min in 
men and 300 mg/min in  women.  
The plasma level at which the glucose first appears in the urine in 
more than the normal minute amounts is known as renal threshold. The 
renal threshold is normally  about 300 mg/dL.  However, the actual 
renal threshold is   corresponds to a venous level of about 180 mg/dL.      
The difference  between the ideal and actual threshold is called splay. 
Glucose transport mechanism: 
In  the  early  part   of  the  PCT  ,  sodium  and  glucose  are  
cotransported from the tubular lumen by SGLT 2, Na+ is pumped out of 
the tubular cells by  Na+-K+ ATPase in the basolateral membranes, and 
glucose is transported to  the interstitium by GLUT 2. Other substances 
likeaminoacids , lactate, inorganic  phosphate ,H⁺  and   cl⁻are  also 
transported along with sodium 
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Water excretion: 
The total amount of fluid filtered through the glomerulus is about 
180 litres /day. But   daily urine volume averages about 1 litre .At the 
end  of  the  proximal  tubule,70%  of  the  filtered  solute  and   water  is  
removed. 
The descending limb of Henle’s loop is permeable to water, but 
the ascending limb is  not permeable. Distal tubule is also impermeable 
to water. 
 The  antidiuretic hormone increases the permeability of the 
collecting ducts to water. The key to the action of vasopressin on the 
collecting ducts is aquaporin-2. Unlike the other aquaporins, this 
aquaporin is stored in vesicles in the cytoplasm of principal cells. 
Vasopressin causes rapid insertion of these vesicles into the apical 
membrane of cells. 
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Mechanisms of progressive kidney disease: 
            1.   glomerular  hyperfiltration  and hypertension. 
            2.   proteinuria  
            3.  cytokine bath 
            4.  nephritogenic  T lymphocyte  activation 
           5 . epithelial mesenchymal  transition 
           6.  fibrosis 
 
With the loss of functioning nephrons, glomerulotubular balance 
is maintained, by which the residual tubules adjust to increases in   
glomerular filtration with necessary  alterations in reabsorption or 
excretion of filtered water and solutes in order to maintain homeostasis.  
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TUBULAR FUNCTION IN CHRONIC RENAL FAILURE: 
 
1. The tubules lose the capacity to excrete sodium leading  to 
intravascular volume expansion, edema and hypertension 
 
2. Patients with progressive renal injury gradually lose the capacity 
either to dilute or concentrate their urine, and urine osmolality 
becomes   fixed about 350mOsm/L  
 
3. Potassium excretion is impaired leading to hyperkalemia 
 
4. With loss of renal function, there is loss of H+ pumps  in the 
intercalated cells of collecting duct and reduction in 
ammoniagenesis leading to non delta acidosis 
 
5.  Calcium and phosphate homeostasis is impaired leading to 
hypocalcemia, increased PTH secretion and hyperphosphatemia, 
bone demineralization  leading to secondary hyperparathyroidism 
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The  elderly population is the rapidly  growing age group in the  
World,  and  they  constitute   the  largest  group  with  CKD.   The   GFR  
begins to decline at age 40 and drops by 8 ml/min/1.73 m². Elderly 
individuals lose 30% of kidney size by 8th decade and renal mass  
decreases to 300 g by the age of  90 years. 
Histologic changes  in the aging kidney: 
Glomerulus   - basement membrane becomes thickened, increase 
mesangial matrix, focal and  global sclerosis, hypertrophy.  
Podocytes - Fusion, detachment, vacuoles. Tubules undergo  
atrophy, tubular cast, monocytes infiltrates,  fibrosis of interstitium 
Atrophy of afferent and efferent arterioles may be seen. The vessels 
sometimes develop hyalinosis and aglomerulus  vessels are formed 
Functional changes in the aging kidney: 
-  After 40yrs renal blood flow decreases by 10% per year. 
-  Reduction in GFR  by 0.87 ml/min per year. 
- Accelerated  Renal vascular resistance 
-  Diluting capacity is reduced 
-  Reduction in concentrating capacity  
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-  Renal reserve is maintained 
Methods of determining GFR: 
Ideal filtration marker: inulin clearance is the Gold standard for 
GFR assessment but is difficult to use in routine practice  
Other exogenous markers  : Iohexol ,51Cr EDTA; 125 I-iothalamate,   
99mTc-DTPA. 
Endogenous markers:  
Endogenous substances, such as serum creatinine or serum 
cystatin C can be used to estimate GFR. 
Limitations of creatinine: 
1.Creatinine generation :  
Creatinine generation is proportional to the muscle mass. As a 
result creatinine  generation is higher in male than in women, in younger 
than in older individuals and in blacks than in whites. Creatinine 
generation is also affected by meat intake because the process of 
cooking converts a variable portion of creatine to creatinine.  Creatinine 
production is also affected by low protein diet. 
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2.   Creatininefiltration: 
As age advances, excretion decreases resulting in underestimation 
of GFR. 
3.  Creatinine Secretion: 
(i) because of tubular secretion, tends to overestimate GFR  by 
about 10%. (ii) drugs like  cimetidine, trimethoprim inhibit secretion  
4.  Creatinineassay  :  
Large differences  between laboratories in calibration of the 
creatinine assays may lead to differences in interpretation of values.  
5. Increase in extrarenal elimination  with decreasing GFR (degradation 
of creatinine by bacterial overgrowth in small bowel) 
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CYSTATIN C: 
1.   It  is  used  as  an  substitute   to  serum  creatinine  or  its  estimation  
equations in elderly people susceptible for muscle mass variation 
and hence, creatinine production 
2.  It used as a substitute for  serum creatininein identifying old 
people with initial decrease in GFR. 
3. Serum cystatin C–based GFR equations were nearly comparable 
to MDRD estimates and an equation combining it with  
serum creatinine, age, sex and race yielded the best measurement  
of GFR 
 
DISADVANTAGES : 
1. There is no definite normal range and , method of  estimation  are 
not standardized for clinical use. 
 
2.   The test is not commonly   used and availability is rare.  It is very 
expensive  compared to serum creatinine 
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3.  Excreted more extra renally  in renal failure. 
 
The two most frequently used equations for evaluation GFR are 
serum creatinine based: Cockcroft-Gault (CG) and the Modification of 
Diet in Renal Disease (MDRD) equations. 
 
CG  EQUATION: 
This is one of the most frequently  used equations,  among aged  
people, although it was initially derived from  younger individuals. 
The CG equation is as follows: 
   Cr.cl   =   
[ଵସ଴ି௔௚௘	௜௡	௬௥]ି௪௘௜௚௛௧	௜௡	௞௚
ୱ.ୡ୰ୣୟ୲୧୬୧୬ୣ(୫୥/ୢ୪)×଻ଶ    
 
The above equation should be multiplied by 0.85  for female. 
 
MDRD equation   is as follows: 
    GFR  =1 .86  × (Serum creatinine)⁻¹·¹⁵⁴ ×(age) ⁻⁰·²⁰³ 
Multiply by 0.742  if patient is female 
Multiply by  1.212   if patient is black 
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Serum Creatinine  and Cystatin C  based equation: 
Estimated GFR = 177.6 × S.creatinine× 0.65×Cystatin c⁻⁰·⁵⁷× 
Age⁻·²⁰  ×  (0.82 )  if female,  ×( 1.11 )  if  black. 
 
Limitations of CG and MDRD equations 
1.  Renal or extrarenal conditions influencing  plasma level  of 
creatinine. 
2.  Factors modifying creatinine  measurement  -Ketones, glucose, 
drugs such as cephalosporins altering the  assay  
3. Differences in muscle mass or food intake - Extremes of body 
mass, only vegetarian diet or protein-rich food  or persons who 
are amputated. 
4. Standardization error 
Presently, MDRD is the widely used method to measure  GFR in 
older  individuals. 
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CKD was defined by the reduction of glomerular filtration rate 
(GFR) to less than 60 mL/min/1.73 m²and/or presence  of kidney 
damage, such as proteinuria (albuminuria >30 mg/g of creatinine), 
glomerular-based or tubular-based hematuria, or abnormal renal 
imaging and pathologic abnormalities of 3 months’ duration or longer, 
irrespective of the cause.  
In 2002, the national kidney  foundation kidney disease outcomes 
quality initiative (KDOQI)  published  guidelines to standardize 
definition of CKD. 
 eGFR  Markers of 
kidney 
damage 
Stage one >90 Normal to high Present 
Stage two 60 -89 Slight Present 
Stage three 30-59 Moderate Not required 
Stage four 15-29 Severe Not required 
Stage five < 15 Kidney failure Not required 
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Kidney damage  is referred to as   deviations or markers of Injury, 
including abnormalities in blood or urine biochemistries or radiological 
studies. 
This guidelines  has many limitations. 
As   the   eGFR  formulas   contain   age,   older   individuals   are  
more   likely   to   be   classified  as   stage   3  CKD.  Many   of  these  
individuals   have   normal   serum   creatinine,   no   albuminuria,   and   
values that are in the range 50 to 60 mL/min/1.73 m2. Such values could 
represent misclassification of CKD.  
These findings have led to an updated classification of stage of  
CKD by the Kidney Disease Improving Global Outcomes (KDIGO), 
published in  January 2013.  Similar to KDOQI, CKD in KDIGO is 
defined as “abnormalities of kidney structure or function present for  
>3 months with implications for health.” If the abnormalities are present 
for longer than 3 months, CKD is confirmed. If it is present for less than 
3 months, it is not confirmed. The KDIGO classification changes the  
1-stage classification to a classification based on cause of kidney 
disease, GFR category, and albuminuria category.  
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For the causes of CKD, one first defines whether the kidney 
disease is related  to systemic disease (eg, diabetes or collagen vascular 
disease), and then to the  presumed or observed location of the anatomic 
or pathologic changes in the  kidney (eg, glomerular, tubulointerstitial, 
vascular [including hypertension],  cystic, and congenital). For the GFR 
stages  G1 and  G2 the  presence  of  other   markers  of  kidney  damage  is  
required to be considered CKD. 
With the joint consideration of albuminuria and GFR, individuals 
can be  classified for risk of progression. 
KDIGO classification of CKD: 
GFR STAGES GFR ( ml/min/1.73 m²) 
G 1 >90 
G2 60-89 
G 3a 45-59 
G 3b 30-44 
G 4 15 -29 
G 5 <15 
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Albuminuria stages AER or ACR (mg/24h or mg/g) 
A 1 <30 
A 2 30-299 
A 3 >300 
 
AER- Albumin  excretion rate or albumin creatinine ratio 
  One approach that may help define who has CKD is to use 
cystatin C as a  confirmation measure. Cystatin C is an endogenous 
protein  like, but is  definitely  produced by all nucleated cells, freely 
filtered,  reabsorbed, and  catabolized by the proximal tubules. Most 
researches  have shown that serum  cystatin C levels associate better 
with GFR than does serum creatinine alone, Cystatin C is not dependent 
on muscle mass and  its levels may be influenced by thyroid disease, 
steroid use, and inflammation.  
 KDIGO suggested that in individuals with stage 3a GFR but no 
other markers  of kidney damage, a cystatin-based eGFR be calculated. 
If the cystatin C eGFR is greater than 60, CKD is not confirmed. 
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RISK FACTORS FOR CKD : 
 
 The most common risk factors for CKD are diabetes and 
hypertension.   Longer  duration  and  poorer  control  of  either  of  these  
conditions predispose  greater risk for CKD. Other risk factors include 
obesity, smoking,  hyperuricemia, dyslipidemia, heart  diseases, and a 
family  history  of   kidney   disease.  Certain  conditions  such  as  heart  
failure or cancers that  are more prevalent in elders predispose 
individuals at risk for CKD. 
 
Hypertension : 
 
Hypertension, particularly systolic hypertension, is one of the 
strongest risk factors for CKD. The target BP in individuals with CKD 
is controversial. The Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7), 
the American Diabetes Association, and the  prior KDOQI guidelines 
recommended a target BP of   <130/80 mm Hg  in individuals with 
Chronic kidney disease. 
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As part of the CKD guidelines, the KDIGO also made a BP 
recommendation to  slow progression of kidney disease, recommending 
a target BP of 140/90 mm Hg or less if albuminuria is less than 30 mg/d 
and a BP of 130/80 mm Hg or less if albuminuria is 30 mg/dl or greater. 
Diabetes mellitus: 
 The most common disease that will cause proteinuric kidney 
disease in the elderly is diabetes. 
Functional changes in diabetic nephropathy : 
Three cardinal functional changes characterize the natural history 
of diabetic nephropathy. They are, 
1) Changes in giomerular filtration rate 
2) Proteinuria and albuminuria 
3) Changes in arterial pressure. 
A study of these functional changes will be made easy if one 
understands the five stages of diabetic nephropathy. 
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Stages of diabetic Nephropathy 
1.   Stage of hyperfunction and hypertrophy: 
This stage is characterized by large kidneys and glomerular hyper 
filtration and hypertrophy. The basement membrane mesangium is 
normal.  The  GFR  IS  >  150  ml/min  with  normal  blood  pressure.  The  
urinary albumin excretion may be increased. 
 
2 .  Silent stage: 
In this stage the blood pressure and urinary albumin excretion are 
normal. But structural changes like increased basement membrane 
thickening and mesangial expansion may be present. This situation may 
last for years. 
 
3.   Stage of incipient diabetic nephropathy : 
The patient in this stage are at risk to develop overt nephropathy if 
left untreated. There is persistent microalbuminuria and hypertension. 
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4.   Stage of overt diabetic nephropathy : 
   This stage  is characterized by proteinuria, hypertension and a fall 
in GFR. 
5. Stage of ESRD  
This stage is characterized by uremia with generalized nephron 
closure   and   very  low  GFR. 
 
Pathology of diabetic Nephropathy: 
The key change in diabetic glomerulopathy is augmentation of   
extracellular material. The earliest morphologic abnormality in diabetic 
nephropathy is the thickening of the glomerular basement membrane 
(GBM) and expansion of the mesangium due to accumulation of 
extracellular matrix. 
The nodular lesion described by kimmelsteil and Wilson has been 
considered virtually specific for diabetes. The nodules are well 
demarcated, hard eosinophilic and periodic-Acid Schiff (PAS) positive 
located in the central region of peripheral glomerular lobules. The 
nodules are seen in the  presence of diffuse lesions and this reflects their   
appearance  only after  a long period of disease. 
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The diffuse glomerular lesion comprises increase in mesangial 
matrix extending to involve capillary loops. In more severe cases the 
capillary wall thickening and mesangial expansion lead to capillary 
narrowing and eventually to complete hyalinisation. In this advanced 
state, periglomerular fibrosis is present. The exudative lesions are highly 
eosinophilic, rounded homogenous structures seen in the capsular space 
overlying a capillary loop(fibrin cap) or lying on the inside of bowman’s 
capsules (capsular drop). 
The glomeruli and kidneys are typically normal or increased in 
size initially thus distinguishing diabetic nephropathy from most other 
forms of chronic renal insufficiency, wherein renal size is reduced  
(except renal amyloidosis and polycystic kidney disease). 
  Immunofluorescence microscopy may reveal deposition of 
immunoglobulin G along the GBM in a linear pattern but this is not 
diagnostic. immune deposits are not observed. The renal vasculature 
typically displays evidence of atherosclerosis usually due to 
concomitant   hyperlipidemia and hypertensive  arteriosclerosis. 
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The severity of diabetic glomerulopathy is estimated by the 
thickness of the peripheral basement membrane and mesangium and 
matrix expressed as a fraction of appropriate spaces (eg. Volume 
fraction of mesangium/glomerulus, matrix/mesangium or matrix/ 
glomerulus). 
Three major histologic changes occur in the glomeruli of persons 
with diabetic nephropathy. First, mesangial expansion is directly 
induced by hyperglycemia via increased matrix production or 
glycosylation of matrix proteins. Second, GBM thickening occurs. 
Third, glomerular sclerosis is caused by intraglomerular hypertension. 
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CLINICAL COURSE : 
a.  Early  phase  
The increase in GFR and renal plasma flow is accompanied by 
increase in the kidney size by  about 20%.  In the silent phase there is no 
clinically evident proteinuria but a sensitive radioimmuno assay for 
urinary albumin shows supranormal excretory rates in a proportion of 
the population. This subclinical  albumin  excretion  is  termed as 
microalbuminuria. In normal individuals it is 1.5 to 20 µg/min and these 
levels aretermedmicroalbuminuria. The term persistent or clinical 
albuminuria is used when the AER is more than 200 µg/min. The 
prevalence of microalbuminuria ranges from 5-37% in type 1 DM and 
around 47 % in type 2 DM subjects. 
Late phase: 
This phase is also called clinical nephropathy. The appearance of 
persistent proteinuria(300 mg/day)  signals the onset of clinical 
nephropathy. There is a gradual decline in GFR to end stage renal 
failure. 
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Serum creatinineis found to rise sooner in proteinuric patients 
with high blood pressure.  
 
In established nephropathy arterial blood pressure is elevated but 
in some the BP is in the normal range. Fluid retention is common with 
the advent of clinical proteinuria. A diabetic can have primary or any 
secondary form of hypertension resulting from diabetic nephropathy, 
described as  “diabetic hypertension”. It is volume dependent, low renin, 
low aldosterone hypertension that responds well to  diuretics and fluid 
restriction. 
 
The data suggest that at least for overtly proteinuricdiabetic 
kidney disease (urine albumin/creatinine ratio >300 mg/g), blockade of 
the renin- angiotensin system slows kidney disease. 
 
The KDIGO recommended ACEIs or ARBs for all individuals 
with diabetes and an albuminuria level of 30 mg/d or higher, and for 
nondiabetics if at least 300mg/d. 
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In many randomized studies  tighter glucose control was 
associated with less frequent development or progression of 
microalbuminuria. However, none of these studies showed an 
association between tight glucose control and a lesser decline in GFR. 
 
As tight control is not associated with improved outcomes and the 
risk of  hypoglycemia is higher in those with CKD, the recent KDIGO 
CKD guideline has  proposed different hemoglobin A1c targets in those 
with diabetes and CKD. 
 
The recommended hemoglobin A1c level is approximately 7%. 
Individuals at increased risk for hypoglycaemia  should not be treated to 
a   Hb A1c    level lower than 7%. 
 
Acute Kidney Injury: 
Acute kidney injury (AKI) is increasingly recognized as a risk 
factor for both the development of CKD and its progression in the older 
adult population.  
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Furthermore, CKD is recognized as a risk factor for the 
development of AKI relating to decreased renal reserve. Older 
individuals are at increased risk for AKI, owing to aging-related 
decreased renal reserve as well as an increased use of medications and 
procedures that increase the risk of AKI.  
 
NONRENAL-RELATED OUTCOMES  
1. Cardiovascular : 
Renal disease has been shown to be an important factor 
influencing   heart disease   and patients with CKD should be considered  
a “highrisk” individuals for heart  disease.  
Common  risk factors are : 
Old age,  Male sex,White individuals, elevated   BP ,  increased  
LDL-cholesterol, reduced HDL level, type 2 DM /impaired glucose 
tolerance, smoking, sedentary life style, menopause, stress and  
depression,  family history of  heart  disease. 
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CKD related risk factors :   
Reduced kidney function, Renin-angiotensin-system activity, 
proteinuria, volume  overload, hyperphosphatemia, Higher PTH level, 
Anemia,  Malnourishment,  Inflammatory stimuli, Oxidative stress, 
Infection,  elevated homocysteine levels,  hypercoagulable factors. 
ST-elevation myocardial infarction is  rare in patients  with 
chronic kidney disease. Patients with  CKD  present rarely  with typical 
symptoms like  arm, shoulder, or chest pain  or with increased sweating, 
but more likely to have  cough or dyspnea.  
Cardiac biomarkers such as creatine kinase and its subfraction 
CK-MB  and troponins are frequently and intermittently increased in 
patients with renal disease. Thus,  investigating   acute coronary 
syndromes  in   aged  patients  with   chronic  kidney  disease   is  very  
difficult. 
2.   Chronic  kidney  disease  (CKD)-related  bone  disease    is  known  as  
renal or uremic osteodystrophy. It is associated with abnormalities  in 
bone and mineral metabolism that leads to disturbance in calcium, 
phosphorous, vitamin D, and PTH level.  
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It  consists of a pattern of conditions that are classified     based on bone 
biopsy features  including mixed uremic osteodystrophy, osteitis fibrosa, 
osteomalacia, and adynamic bone disease.  
 
 KDIGO has suggested to define CKD-related bone and mineral 
metabolic disturbances in the setting of a systemic disorder called 
CKD–mineral  bone disease. 
 
 Osteoporosis is a condition   featured   by low  bone mass leading 
to decreased bone strength and increased  susceptibility to fractures. 
Wrist,  spine,  hip   are   the  common  joints  involved.  Osteoporosis  and  
renal osteodystrophy may occur simultaneously in older  patients with 
CKD, which makes difficult to differentiate. 
 
Evaluation : 
Alternate markers of bone metabolism such as serum intact  PTH,  
ionized calcium , phosphorus, alkaline  phosphatase, and bicarbonate 
levels should be measured  initially. 
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Increased parathyroid  hormone   levels may indicate  high 
turnover bone disease. The desired target level for intact Parathyroid 
hormone in CKD is  not known. 
Several diagnostic modalities  are available to assess bone health 
like quantitative computed tomography (qCT), dexa scan and heel 
ultrasound. 
Bone Biopsy  remains the investigation of choice  for the 
diagnosis of renal osteodystrophy and  evaluation   of bone architecture. 
       The treatment of osteoporosis includes changing modifiable risk 
factors and using  medical management. 
(1) Smoking and alcohol intake should be stopped. 
(2) Exercise: Moderate physical activity has been related with 
improvement in bone  strength  and reduced risk of  fractures.  
(3) Calcium and vitamin D requirements: Vitamin D deficiency is 
common in aged individuals commonly during winter. It may be caused  
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by decreased synthesis, insufficient food intake, dietary  restrictions, and   
sedentary lifestyle in dialysis patients.  
The effects of vitamin D on other systems are also more 
commonly seen. 
Deficiency of 25(OH)vitamin D may be associated with increased  
risk  of   heart  diseases  in  patients  with  peritoneal  dialysis  (PD)  and  
higher risk of acute  coronary  syndromes in  men. 
About  2000 mg/d of elemental calcium  should be taken in CKD 
stages 3 to 5. A daily calcium intake of 1200 mg and vitamin D intake 
of 800 to 1000 IU/d for adults 50 and older is suggested by the national 
osteoporosis foundation. 
(4)  Bisphosphonates: Bisphosphonates are useful in managing 
osteoporosis, but their use in CKD Stages 4 and 5 is  doubtful.  
(5) Calcitonin: Calcitonin  adheres   to osteoclasts and prevents  bone 
resorption.    It  has  a  few  side  effects   and  can  be  given   intranasally.   
It protects bone mass in  post   transplant   patients.  
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6.Selective estrogen receptor modulators (SERM) : 
Raloxifene was associated with a greater increase  in spine BMD,   
decreased vertebral fractures, and minimal effect on nonvertebral 
fractures. It can be used safely in women with osteoporosis. 
(8) Cinacalcet:  
  It acts by increasing  the sensitivity  of calcium sensing receptors 
in the parathyroid gland to calcium, and plays a important part in   
homeostasis of parathyroid hormone levels. It  helps in modifying bone 
histology, decreasing bone turnover, and reduction in fibrosis in patients 
with secondary hyperparathyroidism. 
(9 ) Anabolic agents. 
Risk factors for  AKI  in elderly 
1. Comorbid conditions.  
The incidence of comorbid conditions that increase the risk for 
AKI  dramatically increases with age. Hypertension,   diabetes mellitus, 
athero-sclerosis, and  heart failure  are  all  conditions more commonly  
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encountered in older individuals, and all can directly or indirectly 
increase the risk for AKI.  
Atherosclerosis and hypertension impair the autoregulatory 
capacity of the kidney to maintain perfusion in the setting of 
hypotension. Thus, modest decreases in systemic blood pressure may be 
associated with significant ischemic damage to the kidney. 
More directly, these conditions are associated with the 
development  of  glomerulosclerosis  and  CKD  as  well  as  the  use  of  
medications (such as  ACEs and ARBs) that increase the risk of AKI in 
certain settings. Another comorbid condition more commonly seen in 
the elderly is prostatic disease, which when severe can lead to urinary 
tract obstruction.  
2.chronic kidney disease 
3.Polypharmacy 
  Elderly patients are often prescribed number of drugs which may 
lead to AKI. 
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4. Structural, functional, and hemodynamic changes in the kidney 
associated with aging. 
 a. Structural changes 
 i. Total renal mass declines with age 
ii. The number of functioning glomeruli decreases with age 
 b. Functional changes  
i. Variable decline in GFR with age 
ii. A change in sodium metabolism leads to reduced  ability to 
concentrate urine, and increases the susceptibility to volume  depletion    
in the elderly. 
c. Hemodynamic changes  
i. Decreased renal blood flow and decreased blood flow reserve 
ii. Increased renal vascular resistance 
iii. Impaired renal vasodilatation and exaggerated renal vasoconstriction 
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iv. Impaired autoregulation 
v. Impaired nitric oxide production 
5. Cellular and molecular changes in the aging kidney that increase the 
risk for AKI.  
ETIOLOGY OF AKI IN THE ELDERLY 
1.Prerenal 
The causes of AKI in the aged  patients   span  typical causes seen 
in other populations.  AKI in this  circumstance is  due to reduced  renal  
blood flow from any cause like   heart failure or depletion of effective 
circulating volume. Older patients are more susceptible to volume 
depletion and dehydration. In part, this is due to impairment in renal 
concentrating ability but also to the use of diuretics, impaired thirst 
sensation and, in some cases, restricted ability to access fluids. 
2.  intra renal: 
1. Vasculature. Acute obstruction of the renal vasculature is an 
uncommon cause of AKI, but can be seen in the elderly patient 
undergoing a vascular procedure leading to cholesterol embolization. 
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2. Acute tubular necrosis (ATN).  
Acute tubular necrosis is the commonest   cause of AKI in the 
elderly. Nephrotoxic causes include medications such as 
aminoglycosides, radio- contrast material, and chemotherapeutic agents.  
 Pigments attributable to hemolysis or rhabdomyolysis are less 
common offenders. Major causes include sepsis, severe and prolonged 
volume  depletion, and major surgical procedures (most commonly 
involving the  cardiovascular system). 
 
3. Acute interstitial nephritis (AIN).  
 
4. Glomerulonephritis. A rapidly progressive glomerulonephritis could 
present  as AKI, typically with manifestations in other organ systems. 
Clinicians should  consider this possibility when the urinalysis displays 
dysmorphic red blood  cells, red blood cell casts, and proteinuria. In the 
elderly, the most common  cause of this presentation would be 
antineutrophil cytoplasmic antibody  (ANCA)-associated diseases, most 
commonly p-ANCA or positive antimyelo- peroxidase. 
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Postrenal causes of AKI are more commonly encountered in 
elderly patients. Common causes in the male patient include prostate 
disease (benign prostatic  hypertrophy or prostate carcinoma) or urethral 
stricture,  whereas in females  pelvic malignancies are the primary 
cause. 
Kidney Disease Improving Global Outcomes (KDIGO) criteria for 
the diagnosis of acute kidney injury 
 Stage 1 AKI:  
  1.5–1.9 times baseline, OR >0.3 mg/dL rise  in the s. creatinine, 
or urine output <0.5 mL/kg per hour for 6–12 hours  
Stage 2 AKI:  
2–2.9 times baseline rise  in the serum creatinine OR urine output 
<0.5 mL/ kg per hour for more than  12  hours 
Stage 3 AKI: 
3  times baseline rise  in the s.creatinine, or rise in   s.creatinineto  
more than 4 mg/dL, or  urine output  less than  0.3 mL/kg per hour for    
  
57 
 
more than 24 hours, or nil urine output for more than   
12  hours,  OR  the  initiation  of  dialysis,  OR,  in  patients  less  than  18  
years, reduction in glomerular filtration  rate  less than 35 mL/min per 
1.73 m² 
 
Treatment of AKI 
There are no specific therapies for AKI once it is has occurred. 
Thus the management of AKI is largely supportive, through 
maintenance of adequate  renal blood flow, avoidance of further injury, 
and renal replacement support.  
 
The decision to initiate renal replacement therapy (RRT) in 
elderly persons may be difficult and complex, given the possibility that 
older persons may not fare well on this aggressive, life-sustaining type 
of therapy and may have comorbid conditions that lead to a very poor 
overall prognosis.  
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Glomerular diseases in elderly: 
 
1. Acute nephritic syndrome (ANS) is characterized by the sudden 
onset   of proteinuria and hematuria, often accompanied by 
hypertension, edema and reduced renal function. An antecedent 
streptococcal (throat or skin) or an active staphylococcal (skin or 
soft tissue) infection may be documented (poststreptococcal 
glomerulonephritis or staphylococcal-related glomerulonephritis). 
 
2.  Rapidly progressive glomerulonephritis presents in a more 
insidious fashion and also manifests hematuria and proteinuria, 
but is characterized by a progressive and relentless  loss of renal 
function and less evidence of edema and hypertension. 
Development to end-stage renal disease (ESRD) may occur 
within few   days or weeks. Although an infection may also be 
present, such features are usually absent, especially in the elderly. 
If caused by a systemic disease (such as vasculitis) extrarenal 
symptoms and signs are commonly present  (eg, palpable purpura, 
lung hemorrhage).  
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3.  Nephrotic syndrome is characterized by the abrupt or insidious 
onset of marked proteinuria (usually more than 3.5 g/d up to more 
than 20 g/d), with  or without hematuria, but with a prominent 
tendency for edema, hypoalbuminemia, and hyperlipidemia. 
Renal function is variable and may be normal or reduced.  
In the elderly, the peripheral edema may be severe if there is 
concomitant congestive heart failure or venous insufficiency.  
 
4.  Asymptomatic hematuria and/or proteinuria is characterized by 
symptom-free (eg, no lower urinary tract symptoms such as 
dysuria or frequency) excretion of abnormal numbers of intact 
erythrocytes and/or increased amounts of protein (albumin), or 
both, in association with normal renal function, normal blood 
pressure, and absence of edema. 
 
  This presentation is often discovered incidentally during a 
routine urinalysis, although at times the hematuria may be 
episodic and gross or macroscopic, thus bringing the patient to the 
physician’s attention. Most often the hematuria is microscopic 
and persistent or episodic. 
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5.  Chronic glomerular disease can be said to be present when any of 
the conditions causing glomerular injury have progressed slowly 
to definitely impaired renal function  nearly always with an 
increased serum creatinine concentration. 
 
One feature of the hematuria observed in the glomerular disease 
syndromes  is the excretion of increased numbers of abnormally shaped, 
smaller than normal (microcytic), poorly hemoglobinized 
(hypochromic) erythrocytes in the  urine. This is also known as 
dysmorphic or glomerular hematuria. 
 
Five lesions account for more than 80% of the lesions of primary 
glomerular disease in the elderly: membranous nephropathy (MN); 
mesangial, endocapillary, or focal proliferative glomerulonephritis; 
focal and segmental glomerulosclerosis (FSGS); crescentic 
glomerulonephritis; and minimal change disease (MCD). 
 
Idiopathic MN is the most commonly encountered glomerular 
lesion in the  elderly with primary glomerular disease . Membranous  
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nephropathy is  characterized by glomerular capillary wall 
abnormalities with subepithelial deposits of immune complexes that 
appear electron dense by ultrastructural analysis. 
Most patients with MN present with characteristic  features of the 
nephrotic syndrome(>85%), but a few present with asymptomatic 
proteinuria, often without  hematuria. Persistent nephrotic-range 
proteinuria, particularly more than about 4 g/d,  can be associated   with 
a slowly progressive course to ESRD over many years. 
There is also a marked susceptibility  to thromboembolic 
diseases, including  deep venous thrombosis of the legs, and renal   vein 
thrombosis, sometimes  with pulmonary embolism. 
Management : 
Conservative management (salt restriction, loop diuretics,  
antihypertensive agents, mainly angiotensin converting enzyme 
inhibitors  [ACEi], angiotensin receptor blockers [ARB], or direct renin 
inhibitors is indicated when proteinuria is modest(<4 g/d), the 
symptoms of nephrotic syndrome are tolerable and manageable. 
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  Concomitant therapy with a statin to help reduce the 
hypercholesterolemia is often indicated. Prophylactic anticoagulants 
may be indicated when the serum    albumin level is low(<2.8 g/dL), if 
the patient has had a prior thromboembolic event, or has another 
thrombophilic disorder and is at low risk of a bleeding complication of 
anticoagulation. Patients with marked proteinuria (>4 g/d for 6 months 
or longer), those with severe symptomatic nephrotic syndrome, or those 
with progressive renal disease  are candidates for specific therapy. 
 
Cyclical oral cyclophosphamide and glucocorticoids for 6 months 
(Ponticelli regimen) are preferred for initial therapy. 
 
As an alternative, treatment may be initiated with a calcineurin 
inhibitor (CNI; cyclosporine or tacrolimus), alone as monotherapy or 
combined with low-dose steroids  for 4 to 6 months, providing that the 
initial renal function is normal or  near normal. Intravenous courses of 
rituximab, and  mycophenolate mofetil (MMF) plus steroids can be 
used. 
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Mesangial, endocapillary, or focal proliferative 
glomerulonephritis is most commonly a manifestation of an underlying 
streptococcal, staphylococcal, or viral infection. Poststreptococcal 
glomerulonephritis is not a benign disease in  the elderly. It may induce  
acute congestive heart failure. 
Treatment is mainly supportive  with diuretics, bed rest, and salt 
restriction. Staphylococcal-related glomerulonephritismay be associated 
with IgA deposits in the glomeruli and has a poor prognosis. 
IgA nephropathy is common in the elderly . The standard therapy 
for IgA nephropathy is maximum dosage of an ACEi/ARB or DRI. 
Combination of an ACEi and an ARB or a DRI may be more effective 
in lowering protein excretion over the short term, but the  long-term 
benefits and risk of such combination therapy are unknown and  
side effects  may be increased in the elderly with underlying 
cardiovascular disease.  
Patients with proteinuria persisting at more  
than 1 g/d after 6 months of optimal angiotensin II inhibition therapy 
and  Scr  less  than  1.5  mg/dl  could  be  treated  with  cyclical  oral  and  
intravenous prednisone. 
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 FSGS is a common lesion found to underlie proteinuria and the 
nephrotic syndrome in the geriatric population. The characteristic 
feature of the disease is segmental sclerosis affecting only some 
glomeruli. IgM  and C3 deposits are commonly seen in the sclerosed 
segments by immunofluorescence microscopy, and ultrastructural 
analysis shows  diffuse effacement of the foot processes. 
Patients with the FSGS lesion tend to have an insidious  onset of 
nephrotic  syndrome,  often  present  with  some  degree  of  renal   
impairment, and frequently have hypertension. This lesion tends to be  
uncommon in the very elderly (>80 years of age). Proteinuria may be 
marked  and progressive renal failure is common if marked proteinuria 
persists. Patients with nonnephrotic proteinuria (< 2 g/d) largely have a 
benign evolution and can be  managed conservatively with diuretics and 
ACEi, ARB, or DRI. 
Crescentic glomerulonephritis is one of the more common 
primary glomerular  lesions found in elderly subjects .This lesion is 
characterized by abundant multiplication of the cells lining the Bowman 
space and glomerular podocytes(forming crescents) and by necrotizing 
lesions in the glomerular capillaries.  
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Three distinct pathogenetic mechanisms are operative: 
(1) antiglomerular basement membrane (GBM) antibodies producing a 
linear deposit of IgG along the capillary walls; (2) immune complex 
deposits producing a granular pattern of immunoglobulin  along the 
capillary walls and mesangium, and (3) pauci-immune lesions with   
relative absence of immunoglobulin in glomeruli. 
Pauci-immune lesions are frequently (>80%) associated with 
circulating antineutrophil cytoplasmic  autoantibodies  (ANCA) directed 
to myeloperoxidase or proteinase 3 in the azurophilic granules of 
leukocytes. The linear deposit of IgG is commonly caused by anti-GBM 
autoantibody production, whereas the immune complexlesions are 
commonly caused by lupus nephritis, IgA nephropathy, or infections. 
These lesions are frequently associated with the clinical pattern of 
rapidly progressive glomerulonephritis. 
  The   diagnosis of crescentic glomerulonephritis should always 
be suspected when hematuria and proteinuria are found and the serum 
creatinine is increasing rapidly. Urgent specific diagnosis of the type of 
glomerulonephritis by serology (anti-GBM and ANCA in particular)   
and/ or renal biopsy is indicated. 
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Minimal change disease: 
In younger persons, the lesions are   mainly seen at the level of 
the electron microscope, at which diffuse foot process effacement is 
evident. Light microscopy is normal or shows only mild mesangial 
changes and immunofluorescence microscopy is negative or reveals 
only wisps of IgM in the mesangium. In the elderly, superimposed 
lesions of arteriolo nephrosclerosis and global glomerulosclerosis may 
result in imprecision when rendering diagnosis of MCD (by light 
microscopy alone).  
MCD  is  one  of  the  common  cause  of  the  idiopathic   nephrotic  
syndrome in the older adult, accounting for about 10% to 20% of all 
cases, diminishing in frequency with even more advancing age. MCD in 
the older adult is typically associated with the abrupt onset of a full-
blown nephrotic syndrome with scant hematuria and normal blood 
pressure for the person’s age. 
 MCD in the elderly is commonly  associated  with  acute kidney 
injury  (AKI).  If  the nephrotic  syndrome  is severe, treatment with oral  
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glucocorticoids,  given  once  daily  or  every  other   day  in  doses  of  1  
mg/kg/d (maximum dose of 80 mg daily or 120 mg every other  day) are 
usually given. 
 Adjunctive use of short-term oral cyclophosphamide  
(1.5–2mg/kg/d for 8–10 weeks)  or a CNI-based regimen  can be offered   
for those few patients with frequent recurrences. Treatment must be 
prolonged in many cases, for 16 to 20 weeks. 
  
68 
 
Common secondary glomerular diseases in the elderly: 
1. Diabetic glomerulosclerosis (diffuse and nodular types) type 2 
diabetes 
2. Systemic necrotizing and crescentic glomerulonephritis  
3. Systemic amyloidosis (AL type, primary and secondary to 
multiple myeloma) 
4. Nonamyloid monoclonal immunoglobulin deposition diseases  
5. Idiopathic nodular glomerulosclerosis 
6. Malignancy-related glomerulopathy. 
7. Drug-related glomerular disease (nonsteroidal anti inflammatory 
agents, cancer chemotherapeutic agents, bisphosphonates, 
interferons). 
Amyloidosis is a cause of the nephrotic syndrome in about 10% 
to 15% of elderly patients. It may present as a renal disease  without any 
extrarenal manifestations but more frequently some clues to the  
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correct diagnosis are present, such as carpal tunnel syndrome, 
macroglossia, easy bruising, postural hypotension, diarrhea, 
organomegaly, cardiac disease, or liver disease. In the  elderly, AL 
amyloidosis is the most common disease, but rarely AA amyloidosis or 
even  hereditary amyloidosis  may be the cause. 
 
The Congo red stain is positive and 10-nm to 12-nm 
nonbranching fibrils are found on   electron microscopy. Marked 
proteinuria (up to 20 g/d or more) and some impairment of renal 
function with mild hypertension is the rule. Plasma levels of free 
monoclonal immunoglobulin light chains (typically lambda) are 
frequently increased  and  a monoclonal paraprotein can often be found 
in the urine. 
 
About 10% of patients with AL amyloidosis have a frank multiple 
myeloma on bone marrow examination or bone survey. Nephrotic 
syndrome and reduced renal  function are ominous prognostic signs and, 
in the absence of therapy, nearly all patients  die or progress to ESRD in 
a matter of a few years from diagnosis . Management  include high-dose 
melphalan plus steroids, or bortezomib and lenalidomide.  
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 Nonamyloid monoclonal immunoglobulin deposition diseases 
(MIDD)  are  also  a  common  cause  of  renal  disease  in  the  older  
population. They may collectively account for 10% to 15% of cases. 
The diseases consist of light chain MIDD (usually  kappa light chain), 
heavy chain MIDD, light-heavy chain MIDD, IgG MIDD, monoclonal   
cryoglobulinemia, crystal cryoglobulinemia, and immunotactoid 
glomerulopathy. 
These diseases share in common the deposition of a nonamyloid 
monoclonal protein   in the glomerular capillaries, lacking the  b pleated 
sheet conformation, causing structural and functional deficits including 
nephrotic syndrome and progressive renal failure. 
Idiopathic (nondiabetic) nodular glomerulosclerosis is a recently 
described condition  in which the pathologic findings of nodular DGS 
are found in patients who have  no evidence of diabetes mellitus. The 
patients tend to be elderly women with a  strong history of smoking and 
hypertension. The pathogenesis is unknown and the prognosis is poor. 
No effective treatment is available, other than control of blood pressure   
and stopping smoking. 
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Goodpasture disease  is an uncommon disorder characterized    by 
crescentic glomerulonephritis  and circulating antibodies to  GBM, often 
accompanied by diffuse alveolar hemorrhage. In the elderly it is chiefly  
found in women and overt (alveolar hemorrhage can be observed in less 
than 50%  of cases). There may be a coexisting ANCA-associated 
nephritis/vasculitis  in  as  many  as  20%  of  cases.  With  extensive  
crescents, the prognosis for recovery is poor without aggressive therapy.  
 
Treatment consists of oral cyclophosphamide, oral and 
intravenous glucocorticoids, and aggressive plasma exchange.  
 
Maintenance immunosuppressive therapy is usually not required 
unless concomitant ANCA-associated disease is present. Dialysis-
dependent patients with serum creatinine greater  than 6 mg/dL have 
only a 10% chance or less of recovery of renal function. Life threatening  
pulmonary hemorrhage is best treated by high-dose steroids and 
intensive   plasma exchange, which may be life saving. 
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Systemic pauci-immune necrotizing and crescentic polyangiitis is 
among the most common secondary glomerular diseases affecting the 
elderly. This condition is similar to the renal-limited form. The systemic 
forms are (1) granulomatous polyangiitis (formerly called Wegener 
granulomatosis) affecting the  kidneys, lungs, upper airways, sinuses, 
sclera, and auditory canal with evident granulomas  in the affected 
vascular tissue; and (2) microscopic polyangiitis (MPA), also  affecting 
the kidneys, lungs, skin, and joints, but without vascular tissue 
granulomas. 
Both are strongly associated (>90%) with ANCA; mostly 
antiproteinase 3 in GPA and anti myeloperoxidase in MPA. Systemic 
features of fever, cough, myalgias, Pulmonary hemorrhage, necrotizing 
cutaneous angiitis, sinusitis, and upper and lower airway disease  can be 
present.  
The treatment is identical to that described earlier for renal 
limited necrotizing and crescentic glomerulonephritis but the prognosis 
may be poorer  because of the multiorgan involvement. Patients who are 
dialysis  dependent for less than 2 weeks are likely  to benefit from the  
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addition of intensive plasma exchange  but the risk of complications is 
great.  Courses  of  rituximab  are  emerging  as  an  alternative  to  
cyclophosphamide-glucocorticoid regimens, especially in relapsing 
disease. 
A high degree of suspicion for underlying glomerular disease 
needs to be present when hematuria and proteinuria are present 
concomitantly and  an increasing serum creatinine should be viewed 
with a sense of urgency. 
The atypical   clinical features of acute and chronic glomerular 
disease in the elderly should be  remembered. 
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Vascular diseases in elderly:  
Causes of vascular injury to kidney:  
When classified   by size of the vessel, the vascular diseases can 
be classified into  those affecting   (1) the microscopic vessels,  
(2) arterioles, and   (3) the main renal arteries. 
 A   rise   in  renal  vascular   resistance  and  decline   in  effective  
renal   blood  flow are observed  as BP decreases.   Although the GFR is 
relatively maintained, renal insufficiency may occur in some   
hypertensive patients.  
As age advances, the total number of effective glomeruli decrease    
by 30 to 50% as the number  of sclerotic or abnormal glomeruli 
increases. The ischemic changes are modifiable    initially. 
However, with hyalinosis, the pathology continues to  glomerular 
sclerosis.  With  continued  pathogenesis  the  lesion   progresses   to  the  
formation of aglomerular arterioles. When the vascular lesions  involve 
most of the glomeruli  and severe, the entire kidney undergoes ischemic  
atrophy. 
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Intrarenal Arterioles and Interlobular Arteriolar  Disease: 
 
Hypertension, arteriosclerosis and aging  affect the arterioles in 
the kidney causing afferent and efferent arteriolar atrophy.     
Impairment  of auto regulation with  glomerular vasodilatation occur.  
 
This is accompanied by hypertrophy of the intact nephrons  
leading to intraglomerular hypertension, excretion of albumin in urine, 
and   sclerosis of glomeruli. The histologic changes like hyperplastic 
elastic arteriosclerosis, intimal thickening, reduplication of the lamina 
elastica interna,  and hyalinization are seen. These changes lead to 
decline  in renal blood flow along with progressive  ischemic  changes 
seen in  the glomeruli and renal tubules. 
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Atherosclerotic Renal  Artery Stenosis 
It is  the presence of  cross-sectional arterial luminal constriction, 
which may or may not have any important  hemodynamic effects. 
Atherosclerotic renal artery stenosis commonly causes  occlusion of  the 
ostium and the  early one  third of the renal arteries.  
Only when the luminal diameter is reduced by 70% 
atherosclerotic RAS often becomes clinically significant. Clinically 
severe stenosis leads to parenchymal ischemia, atrophy, and loss of 
kidney function. 
 
Diagnosis of atherosclerotic RAS : 
There is no pathognomonic clinical signs. . The development  of 
hypertension after  50 yrs of age, presence of abdominal bruit,  atrophic 
kidney,  frequent  pulmonary edema or  the occurrence of AKI  after 
initiation of ACE inhibitors(ACEi) or  ARBs may  suggest the presence 
of renal artery stenosis.  
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Imaging modalities used are Doppler ultrasound, MR 
angiography with Intravenous gadolinium, CT Angiogram, renal artery 
angiography(gold standard), nuclear renal scan. 
 
Treatment : 
All cases of  RAS need not   be treated because some patients will 
have no clinical symptoms. However, RAS may cause ischemic 
nephropathy with progressive CKD or it may cause  hypertension.  
Percutaneous transluminal renal angioplasty (PTRA) with stents 
has different results depending on the patient selection 
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Urinary tract infections in the elderly : 
Asymptomatic bacteriuria (ASB) is a common manifestation in 
elderly people. The ASB is diagnosed  based on a urine culture from a 
urine specimen that has minimal contamination from a person without 
symptoms or signs referable to urinary infection. For asymptomatic 
female, bacteriuria is defined as 2 successive voided urine specimens 
with growth  of the same bacterial species  in quantitative counts >10⁵  
colony forming units (cfu)/ml. For asymptomatic male, bacteriuria is 
defined as a single, clean-catch voided urine specimen with single  
bacterial strain grown   in a quantitative count 10⁵ cfu/ml. 
Selection and management of ASB in aged  persons is only  
recommended in the following two situations: 
(1)Before performing TURP  and (2) before urologic surgeries  in 
which    bleeding from the mucosa  is expected.  
Old people with various diseases may not be able to report their 
symptoms.  The  only  clinical  symptoms  that  have been  present  with  
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bacteriuria plus pyuria in hospitalized adults with clinically suspected 
UTIs  are dysuria, altered  mental status, and abnormal urine analysis. 
Empirical therapy with a  third-generation cephalosporin is suitable 
drug therapy for older adults admitted with urosepsis until culture and 
susceptibility reports are available. Nitrofurantoin,  trimethoprim-
sulfamethoxazole,   and fluoroquinolones are suitable  first-line drugs 
for outpatients. 
I. for individuals  who do not have an indwelling catheter, 
minimum criteria for starting antibiotics include acute dysuria 
alone or fever (37.9°C ) 
and at least one of the following:  urgency,  frequency, 
suprapubic pain, gross hematuria, costovertebral angle 
tenderness, or urinary incontinence.  
II. For residents who  have a chronic indwelling catheter, 
minimum criteria for initiating antibiotics include the presence 
of at least one of the following: fever, rigors, new 
costovertebral   angle tenderness ,or new onset of confusion. 
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One of the most predominant urologic problems in elderly 
persons, is lower urinary tract symptoms (LUTS).Benign prostatic 
hyperplasiais a disorder that affects the most of aged  patients. 
 
 LUTS are evaluated with both subjective and objective tests. The 
American Urological Association BPH symptom score was designed to 
evaluate subjective complaints. Patients with lower scores are given life 
style changes, with intermediate scores are given the choice of medical 
management  and  patients  with  high   scores   are   given  the  choice  of  
transurethral  surgery.  
 
Patients with hydronephrosis,   hematuria, acute retention of urine 
and recurrent infection are advised surgery. Cystoscopy and urodynamic 
studies are the investigations of choice. Surgical management include  
laser ablation, resection and microwave or radiofrequency  therapy. 
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Medical management: 
Alpha 1 blockers relaxes the smooth muscle fibers of the prostatic 
gland  and   greatly improve urine flow. Common  nonselective alpha 1 
blockers are terazosin and doxazosin;  selective agents are tamsulosin 
and   alfuzosin. 
 
 5 alpha reductase inhibitors prevent  the conversion   of 
testosterone  to dihydro testosterone, which is a potent  inducer  of 
prostatic glandular tissue. This decline in local androgen stimulation 
results in a reduction of  prostatic volume . 
 
Prostate cancer: About    10%  of  patients  above  65  yr  of  age  
have been found to have prostate cancer. The American Urologic 
Association suggests screening with digital rectal exam and PSA  testing 
annually, beginning at age 50.  A  PSA level  between 4 and 10 ng/ml 
represents a 25% risk of prostate cancer. Patients detected  to have an 
abnormal  DRE or  an increased PSA  are the candidates for prostate  
biopsy. 
 
 
82 
 
Polypharmacy : 
An aged patient is on many prescribed medications, as well as  
over-the-counter medications.  Many of these drugs can have urologic 
adverse  effects. Many common drugs, used for common cold and upper 
respiratory infection  have anti-cholinergic  properties that can increase 
LUTS. The drug list of all aged  patients must be analysed  to  confirm 
that  lower  urinary tract signs or symptoms are not drug related. 
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MATERIALS  AND  METHODS 
PLACE OF STUDY: 
DEPARTMENT OF NEPHROLOGY, NEPHRO  OPD AND 
WARDS, AND MEDICAL WARDS AT STANLEY MEDICAL 
COLLEGE AND HOSPITAL, CHENNAI. 
 
DURATION: 
     June  2014 TO  SEP 2014. 
 
STUDY DESIGN: 
       PROSPECTIVE OBSERVATIONAL STUDY 
 
SAMPLE   SIZE:    75 
ETHICAL COMMITTEE  APPROVAL: 
Study  was  conducted  only  after  getting  approval  of  the  
institutional ethics committee. A  copy of the approval is enclosed . 
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SELECTION OF PATIENTS: 
INCLUSION CRITERIA 
1. Patients age more than 65 years 
2.  Patients with raised urea, creatinine values 
3.  Patients with hematuria, proteinuria, abnormal urine sediments 
4.  Patients with electrolyte imbalance 
EXCLUSION CRITERIA 
 Patients less than 65 years. 
METHODOLOGY: 
 Elderly  patients above 65 years with raised  creatinine  and 
abnormal urinalysis  reports coming to OPD/admission unit/wards from 
June 2014 to September 2014   are included in the study.  Patients will 
be subjected to symptom analysis, clinical examination, laboratory 
investigations and Imaging studies. The final analysis will be made at 
the end of the study to achieve the fore mentioned goals using   
appropriate  statistical   methods. 
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RESULTS   AND DISCUSSION 
 This study included  75 patients. Patients were subjected to urine 
analysis, blood investigations, USG abdomen and other investigations  
as needed as per the proforma.  Renal biopsy was done in 6 subjects as it 
was required for diagnosis .8 patients died during the study due to 
various reasons. 
 
ANALYSIS OF DATA OF STUDY GROUP: 
AGE DISTRIBUTION: 
Age (years) Number of patients Percentage 
65-7O 56 74.66 
71- 80 17 22.66 
>80 2 2.66 
 
TABLE 1:  AGE DISTRIBUTION OF STUDY GROUP 
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Among the 75 patients studied most of the patients were between 
65 and 70 years. 56 (76.66%) patients were between 65-70 years,  
17 patients were between 71 - 80 years. Only  2 (2.66%) patients were 
above 80 years 
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SEX DISTRIBUTION OF STUDY GROUP: 
GENDER NO.OF PATIENTS PERCENTAGE 
MALE 48 64 
FEMALE 27 36 
 
TABLE 2:   SEX   DISTRIBUTION   OF   STUDY  GROUP 
Among the 75 patients, 48 (64%) were males and 27(36%)  
patients were females.  
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PREVALENCE OF DIABETES AND HYPERTENSION  
IN STUDY GROUP: 
 No. of patients Percentage 
DIABETES 39 52 
HYPERTENSION 26 34.66 
BOTH 7 9.33 
 
TABLE 3 :   Prevalence   of   Diabetes  and Hypertension  in   Study  
Group  
 
The prevalence of diabetes in the study group was 39 patients 
(52%)and that of hypertension was among 26 (34.66%) patients. Both 
diabetes and hypertension were seen in 7 (9.33%)patients. 
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TABLE 4:    DISTRIBUTION OF  SYMPTOMS IN 
THE STUDY   POPULATION  
 
SYMPTOMS NO.OF PATIENTS PERCENTAGE 
Pedal edema 24 32 
breathlessness 8 10.66 
oliguria 4 5.33 
Burning micturition 12 16 
hematuria 9 12 
fever 5 6.66 
anemia 5 6.66 
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ULTRASOUND FINDINGS  IN THE STUDY GROUP: 
USG FINDINGS NO.OF PATIENTS PERCENTAGE 
Contracted kidneys 35 46.66 
Normal sized kidneys 35 46.66 
Enlarged kidneys 3 4 
Simple cysts 2 2.66 
Enlarged prostate 4 5.33 
Renal/ureteric calculi 2 2.66 
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TABLE  5 :  DISTRIBUTION   OF   USG FINDINGS  IN  STUDY 
GROUP 
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The USG findings in the study group was as follows :  contracted 
kidneys found in 35(46.66%) patients which indicates end stage renal 
disease(ESRD). Normal sized kidneys found among 35(46.66%) 
patients. Increased size with multiple cysts seen among 3(4%) patients. 
Simple cysts seen among 2(2.66%) patients. Enlarged  prostate seen in  
4 (5.33%)  patients. Renal /ureteric calculi seen in 2 (2.66%) patients 
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PATTERN OF RENAL DISEASES IN THE STUDY 
POPULATION : 
DIAGNOSIS NO.OF PATIENTS PERCENTAGE 
CKD 37 49.33 
AKI 27 36 
Glomerular diseases 6 8 
Others 5 6.66 
 
TABLE   6  :  PATTERN   OF   RENAL   DISEASES   IN   THE   
STUDY POPULATION 
 
Among the 75 patients, 37 patients(49.33%) were found to have 
CKD. 27 patients (36%) had AKI. Glomerular diseases seen in  
6 patients (8%). This included membranous nephropathy among  
2 patients, post infectious glomerulonephritis (2 patients), myeloma  
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kidney (2 patients).  Other diseases contributed to 6.66% of the study 
population. This includes polycystic cystic kidney among 3 patients, 
simple cysts seen in 2 patients. 
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ETIOLOGY OF AKI IN THE STUDY POPULATION: 
Causes No. of Patients Percentage 
sepsis 12 44.44 
Acute gastroenteritis 8 29.62 
BPH 4 14.81 
Ca cervix 1 3.70 
 
Among the study population, 27 patients (36%) had acute kidney 
injury(AKI). 
Sepsis contributed to AKI in 12 patients (44.44%). Acute 
gastroenteritis leading to dehydration was seen in 8 patients(29.62%). 
Others were BPH in 14.81%, carcinoma cervix in 3.70%  and  calculi   
in  4.7%   patients. 
98 
 
 
 
  
44%
30%
15%
4%
7%
NO OF PATIENTS
SEPSIS
AGE
BPH
CA CERVIX
CALCULI
99 
 
CITATION 
1. Affifi et al has done a study among 220 elderly patients in Ain 
shams university and Nasser institute hospitals, cairo, Egypt. This study 
showed diabetic nephropathy in 28.2%, hypertensive nephrosclerosis 
25.5%, UTI, cystitis and pyelonephritis in 6.8%, renal stones in 5.9%, 
obstructive nephropathy in 7.6%, simple cysts in 4.5%, CRF of 
unknown origin in 13.1%. Multiple myeloma, lupus nephritis, vasculitis 
recorded in few numbers. 
2. Prakash. J, Saxena RK, Sharma OP et al  has  done  a  study  
among 200 hundred patients over the age of 60 years  in india.  
The clinical presentation included chronic renal failure (42.5%),acute 
renal failure (28%); nephrotic syndrome (14.5%); acute 
glomerulonephritis (7.5%); renal vascular disease (5%) and renal cystic 
disease (2.5%). Diabetic nephropathy, obstructive uropathy and 
hypertensive nephrosclerosis were the major causes of CRF, accounting 
for 80% of total CRF in the elderly. Prerenal ARF, obstructive uropathy 
and sepsis were contributing factors for ARF in 82% of the cases. 
Volume depletion due to gastrointestinal fluid loss and urinary tract 
obstruction on account of enlarged prostate were the leading causes of 
ARF in 20 (35.7%) and 8 (14.3%) cases respectively.  
100 
 
3. Agarwal et al has done a study on spectrum of renal diseases 
in  indian adults. Chronic renal failure (CRF), nephrotic syndrome (NS), 
nephritic syndrome and hypertension were the four common 
presentations seen in 47.8%, 15.03%, 4.6% and 4.9% cases respectively. 
4. Prakash J et al has  done  a  study  on  glomerular  diseases  in  
elderly people. 
The clinical presentation of GN included: nephrotic syndrome 
61.5%, acute nephritic syndrome 29.2%, rapidly progressive GN 6.15% 
and asymptomatic urinary abnormality 3.%. Overall, primary and 
secondary glomerular disease were seen in 72.3% and 27.6% elderly 
patients. 
5 .Renal disease in the elderly and the very elderly Japanese: 
analysis of the Japan Renal Biopsy Registry (J-RBR). Primary 
glomerular disease was the most frequent diagnosis, followed by MPO-
ANCA-positive nephritis, IgA nephropathy (IgAN), and diabetic 
nephropathy.  
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CONCLUSIONS 
1. The study was done to know about  the pattern of renal 
diseases among elderly patients. Majority of the patients were found to 
have CKD(49.33%). 
 Diabetes and hypertension are the major risk factors in CKD 
patients.  
2.  AKI was seen in 36% patients. Sepsis contributed to  large 
part of AKI (44.4%). dehydration due to  gastroenteritis  contributed to 
AKI  in 29.62% patients. Other causes are BPH in 14.81% and Ca 
cervix in 3.7% patients. 
3.  Glomerular diseases were seen in 6 patients (8%).  
This includes membranous nephropathy (2 patients), acute 
glomerulonephritis (2 patients) and myeloma kidney seen in 2 patients. 
4. Other diseases seen in 6.66% of study population. This includes 
polycystic kidney seen in 3 patients, simple cysts in 2 patients. 
 Good control of diabetes and hypertension in younger age may 
prevent the occurrence of CKD as they grow older. Elderly patients 
should avoid taking over the counter drugs. 
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PROFORMA 
PRELIMINARY DATA OF THE PATIENT 
Name:      Age:       Sex: IP NO: 
Address:          PH No: 
DOA:     DOD: 
Occupation:    Income:    Religion: 
Chief complaints 
PAST H/O: Diabetes Mellitus /  Hypertension/ CKD/ Heart disease/  
Syphilis/ TB/ /Seizures/  
Surgical history if any : 
Drug Intake   :  
FAMILY HISTORY :  
PERSONAL HISTORY“ : 
Diet:Veg/Non Veg ;   
Smoking : 
Alcohol intake: 
Bowel and Bladder: Regular/altered 
Marital status: married /unmarried 
Menstrual history if any: Age of menarche / menopause; Regular 
/irregular cycles  
Treatment history: if any  
 
 
GENERAL PHYSICAL EXAMINATION 
Built & Nourishment: Height in cm; Weight in Kg 
Pallor / Cyanosis /Clubbing / Oedema / Icterus / Lymphadenopathy  
Carotid Bruit 
Evidence of any congenital abnormalities 
VITAL PARAMETERS 
Pulse: 
Peripheral pulses: 
BP :inmmHG :  
RR: .../min 
JVP: 
CVS: 
RS : 
ABDOMEN; 
INVESTIGATIONS: 
Blood: 
Hb%                TC, DC ;Bl Urea:              S.Creatinine: 
RBS/  FBS / PPBS                           S Electrolytes : Na    K 
Urine Routine Examination: Albumin  Sugar  deposits 
CXR-PA View: 
ECG: 
ESR:     
Serum CRP:   
Serum Uric acid 
USG ABDOMEN 
ANA,C3 ,C4(if necessary)) 
RENAL BIOPSY(if necessary) 
OTHER INVESTIGATIONS(as required): 
PROVISIONAL / CLINICAL DIAGNOSIS   
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¬}றாநிைலசிகிvைசtகானம¯{¢வமைனtவ¯«
தியவƫக¶tஏபபேவ²வைகயானசி²நரகேநாக
பறியஒ¯ஆº 
 
ஆவாளƫ:  ம¯வ ரபாzய}. 
«¢நிைலபyடேமப~©மாணவƫ, 
ெபா¢ம¯{¢வ~பyடப~©. 
வழிகாy    : ேபராசிƬயƫம¯.எyவ}ெபƫணா}ேடா 
ேபராசிƬயƫ,   சி²நரகவய¢ைற 
அரடா}லிம¯{¢வமைன. 
 
இ|தம¯{¢வஆவ}வவரuகஎனtவளtக~பyட¢.எ}§ைட
யச|ேதகuகைளேகyகº,அதகானத|தவளtகuகைள~ெபறºவா~
பளtக~பyட¢. 
நா}இவாவத}னvைசயாக{தா}பuேககிேற}.எ|தகாரண
{தினா´, எ|தகyட{தி´,எ|தசyடசிtக´, 
இ}றிஇ|தஆவலி¯|¢வலகிtெகாளலாஎ}²அறி|¢ெகாzேட}. 
நா}ஆவலி¯|¢வலகிtெகாzடா´ஆவாளƫஎ}§ைடயம¯
{¢வஅறிtைககைள~பாƫ~பதேகாஅல¢உபேயாகிtகேவாஎ}அ§மதி
ேதைவயைலஎனºஅறி|¢ெகாzேட}.எ}ைன~பறியதகவகஇர
கசியமாக~பா¢காtக~பஎ}பைத­அறிேவ}. 
இ|தஆவஎனtஎவதபƬேசாதைனகைள­, 
சிகிvைசகைள­ேமெகாளநா}«¸மன¢ட}சமதிtகிேற}. 
 
 
 
 
ஆவாளƫைகெயா~ப 
இ~பt 
 
 
ேநாயாளய}ைகெயா~ப 
 
 
 
 
KEY TO MASTER CHART 
RISK FACTORS 
             DM diabetes mellitus 
             HT Hypertension 
              AGE Acute gastroenteritis 
              BPH Benign prostate hypertrophy 
 
 SYMPTOMS 
Pedaledema   1 
Breathlessness   2 
Oliguria  3 
Diarrhoea,vomiting  4 
 Burning micturition  5 
Hematuria  6 
Fever  7 
Anemia 8 
 
USG  FINDINGS 
             C Contracted kidneys 
             N  Normal kidneys 
 
 
 
 
 
S.NO AGE SEX RISK FACTORS symptoms UREA S.CREATININE URINE ANALYSIS USG FINDINGS DIAGNOSIS
1 72 M  DM, HT 1 56 2.4 1+ C CKD
2 68 M      sepsis,DM 3 68 2.5 N AKI
3 75 F DM 2 125 4.2 1+ C CKD
4 74 M HT 2 112 3.6 1+ C CKD
5 65 M DM,HT 1 96 3.5 1+ C CKD
6 68 M HT,BPH 5 62 3.2 N,enlarged prostate AKI
7 82 F DM, sepsis 3 56 2.8 N AKI
8 72 F AGE 4 84 4.1 N AKI
9 75 M DM ,HT 2 156 6.3 2+ C CKD
10 66 M DM 1 126 4 1+ C CKD
11 75 F HT,sepsis 3 72 2.6 N AKI
12 68 M BPH 5 64 2.9 N,enlarged prostate AKI
13 66 F DM,sepsis 7 58 2.8 N AKI
14 73 M DM 2 162 8.2 2+ C CKD
15 76 F AGE 4 54 2.9 N AKI
16 69 M AGE ,HT 4 76 2.9 N AKI
17 74 F DM 1 170 8.5 1+ C CKD
18 75 M BPH 5 84 4.5 N,enlarged prostate AKI
19 68 M DM 1 78 4.7 1+ C CKD
20 77 M sepsis,HT 7 55 2.5 N AKI
21 66 M sepsis,DM 5 112 3.8 N AKI
22 78 F HT 1 84 3.9 trace C CKD
23 65 M DM,HT 8 179 9.3 1+ C CKD
24 68 M DM 1 102 3.4 1+ C CKD
25 70 M HT 5 98 4.5 increased ADPKD
26 68 M sepsis,DM 7 58 2.4 N AKI
27 67 F HT 1 88 3.3 1+ C CKD
28 68 F BPH 5 76 2.9 N,enlarged prostate AKI
29 74 M DM 1 132 4.5 2+ C CKD
30 69 M HT 5 94 4.6 increased ADPKD
31 65 F DM 1 81 4.4 2+ C CKD
32 66 M sepsis,HT 3 60 3 N AKI
33 65 M DM 2 162 8.8 2+ C CKD
34 67 M DM 6 96 4.6 protein 3+ N myeloma
35 68 F sepsis 3 53 2.6 N AKI
36 74 M AGE, HT 4 76 3.4 N AKI
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
37 68 M HT 1 78 3.2 1+ C CKD
38 66 F AGE 4 84 3.1 N AKI
39 70 M DM 1 94 4.5 1+ C CKD
40 68 M DM 8 124 4.9 1+ C CKD
41 66 M 6 92 4 simple cysts simple cysts
42 76 M sepsis,HT 7 78 3.2 N AKI
43 68 F DM,HT 1 142 6.5 1+ C CKD
44 66 F ca cervix 5 84 3.5 N AKI
45 66 F sepsis, DM 7 53 2.6 N AKI
46 65 M HT 1 64 2.5 1+ C CKD
47 65 M HT 6 88 3.1 increased ADPKD
48 71 M DM,HT 6 84 3.4 simple cysts simple cysts
49 73 F AGE 4 58 1.9 N AKI
50 68 M DM 1 102 3.5 1+ C CKD
51 65 F DM 6 78 4.1 protein 3+ N myeloma
52 69 M AGE,DM 4 68 2.4 N AKI
53 68 M calculi 5 76 3.6 N, renal calculi AKI
54 66 M HT 8 88 4.5 1+ C CKD
55 68 F DM 2 156 7.4 2+ C CKD
56 65 M HT 1 86 4.3 1+ C CKD
57 69 F HT 1 108 5.4 1+ C CKD
58 68 M DM 5 70 1.8 N DN
59 65 F calculi 5 65 2.3 N,ureteric calculi AKI
60 66 M DM,HT 1 180 11 2+ C CKD
61 65 M DM 8 126 5.5 1+ C CKD
62 70 F DM 6 88 3.4 2+,RBC 1+ N acute GN
63 66 F HT 1 86 3.5 1+ C CKD
64 68 M DM 6 88 4.5 3+ N MN
65 66 M DM 1 103 3.5 1+ C CKD
66 67 F DM 6 98 4.3 2+,RBC2+ N acute GN
67 66 M HT 6 76 3.6 3+ N MN
68 65 F DM 1 66 2.3 1+ C CKD
69 65 M HT 1 112 4.5 1+ C CKD
70 66 F DM 2 129 4.8 Trace C CKD
71 70 M sepsis 3 58 2.6 N AKI
72 65 M HT 8 66 3.2 1+ C CKD
73 65 F DM 1 162 8.3 1+ C CKD
74 68 M DM 5 56 1.5 2+ N DN
75 84 M AGE 4 74 2.8 N AKI
 
 
 
 
  

